Skip to content
Screener

Bolt Biotherapeutics, Inc. BOLT Q2 2025 earnings

Reported August 14, 2025 · Before market open

Revenue$1.8MBeat by $958.2K
EPS-$4.46Beat by $1.94
Revenue estimate$845.8K
EPS estimate-$6.40

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$68.3K
EPS estimate-$3.89

FAQ

When did Bolt Biotherapeutics, Inc. report Q2 2025 earnings?
Bolt Biotherapeutics, Inc. (BOLT) reported Q2 2025 earnings on August 14, 2025 before market open.
What were Bolt Biotherapeutics, Inc.'s Q2 2025 revenue and EPS?
Bolt Biotherapeutics, Inc. reported revenue of $1.8M and eps of $-4.46 for Q2 2025.
Did Bolt Biotherapeutics, Inc. beat estimates in Q2 2025?
Revenue beat the consensus estimate of $845.8K by $958.2K. EPS beat the consensus estimate of $-6.40 by $1.94.
How did Bolt Biotherapeutics, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 41.5% from $1.3M a year earlier and eps declined 696.4% from $-0.56.
Where can I find Bolt Biotherapeutics, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0001641281-25-000006) and the 10-Q periodic report (0001641281-25-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.